Development and evaluation of a connective tissue phantom model for subsurface visualization of cancers requiring wide local excision
暂无分享,去创建一个
Brian W Pogue | Keith D Paulsen | Alisha V DSouza | Eric R Henderson | Kimberley S Samkoe | Jason R Gunn | Brent D Bates | Niki N Tselepidakis | Dipak B Ramkumar | B. Pogue | K. Paulsen | J. Gunn | K. Samkoe | Dipak B. Ramkumar | Alisha DSouza | E. Henderson | Brent D. Bates
[1] C. Tzeng,et al. Prevalence and prognostic influence of genomic changes of EGFR pathway markers in synovial sarcoma , 2011, Journal of surgical oncology.
[2] D. Goldstein,et al. Significance of Phosphorylated Epidermal Growth Factor Receptor and Its Signal Transducers in Human Soft Tissue Sarcoma , 2017, International journal of molecular sciences.
[3] M. Bernstein,et al. The role of 5‐aminolevulinic acid in enhancing surgery for high‐grade glioma, its current boundaries, and future perspectives: A systematic review , 2016, Cancer.
[4] M. Bouvet,et al. Targeting tumors with a killer-reporter adenovirus for curative fluorescence-guided surgery of soft-tissue sarcoma , 2015, Oncotarget.
[5] B. Pogue,et al. Imaging breast adipose and fibroglandular tissue molecular signatures by using hybrid MRI-guided near-infrared spectral tomography. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[6] Doniel Drazin,et al. Near-infrared imaging of brain tumors using the Tumor Paint BLZ-100 to achieve near-complete resection of brain tumors. , 2014, Neurosurgical focus.
[7] D H Leung,et al. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] M. Bouvet,et al. Eradication of osteosarcoma by fluorescence‐guided surgery with tumor labeling by a killer‐reporter adenovirus , 2016, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[9] Axel Hoos,et al. Analysis of the Prognostic Significance of Microscopic Margins in 2,084 Localized Primary Adult Soft Tissue Sarcomas , 2002, Annals of surgery.
[10] B. Pogue,et al. Application of Fluorescence-Guided Surgery to Subsurface Cancers Requiring Wide Local Excision , 2018, Cancer control : journal of the Moffitt Cancer Center.
[11] Scott C Davis,et al. Topical dual-stain difference imaging for rapid intra-operative tumor identification in fresh specimens. , 2013, Optics letters.
[12] J. Olson,et al. Nonclinical Profile of BLZ-100, a Tumor-Targeting Fluorescent Imaging Agent , 2017, International journal of toxicology.
[13] Joshua S Richman,et al. Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer , 2015, Clinical Cancer Research.
[14] Brian W. Pogue,et al. High Vascular Delivery of EGF, but Low Receptor Binding Rate Is Observed in AsPC-1 Tumors as Compared to Normal Pancreas , 2011, Molecular Imaging and Biology.
[15] H. J. van Staveren,et al. Light scattering in Intralipid-10% in the wavelength range of 400-1100 nm. , 1991, Applied optics.
[16] Brian W Pogue,et al. Advancing molecular-guided surgery through probe development and testing in a moderate cost evaluation pipeline , 2015, Photonics West - Biomedical Optics.
[17] Johannes E. Schindelin,et al. The ImageJ ecosystem: An open platform for biomedical image analysis , 2015, Molecular reproduction and development.
[18] Sanjiv S. Gambhir,et al. Endoscopic molecular imaging of human bladder cancer using a CD47 antibody , 2014, Science Translational Medicine.
[19] Jason R. Gunn,et al. In Vivo Quantification of Tumor Receptor Binding Potential with Dual-Reporter Molecular Imaging , 2012, Molecular Imaging and Biology.
[20] E. Rosenthal,et al. Preclinical Comparison of Near-Infrared-Labeled Cetuximab and Panitumumab for Optical Imaging of Head and Neck Squamous Cell Carcinoma , 2013, Molecular Imaging and Biology.
[21] H. Grossman,et al. Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer. , 2010, The Journal of urology.
[22] Brian W. Pogue,et al. Fluorescent Affibody Peptide Penetration in Glioma Margin Is Superior to Full Antibody , 2013, PloS one.
[23] Jeffrey K. Mito,et al. A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancer , 2016, Science Translational Medicine.
[24] Brian W Pogue,et al. Microdose fluorescence imaging of ABY-029 on an operating microscope adapted by custom illumination and imaging modules. , 2016, Biomedical optics express.
[25] Brian W. Pogue,et al. Fluorescent Affibody Molecule Administered In Vivo at a Microdose Level Labels EGFR Expressing Glioma Tumor Regions , 2016, Molecular Imaging and Biology.
[26] Jia-Lin Yang,et al. Expression of HER1/EGFR protein in human soft tissue sarcomas. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[27] Tayyaba Hasan,et al. Quantitative in vivo immunohistochemistry of epidermal growth factor receptor using a receptor concentration imaging approach. , 2014, Cancer research.
[28] J. Coll,et al. Role of near-infrared fluorescence imaging in head and neck cancer surgery: from animal models to humans , 2015, European Archives of Oto-Rhino-Laryngology.
[29] Xiaoyao Fan,et al. Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker. , 2011, Journal of neurosurgery.
[30] B. Rice,et al. Preclinical Validation of the Utility of BLZ-100 in Providing Fluorescence Contrast for Imaging Spontaneous Solid Tumors. , 2015, Cancer research.
[31] Brian W Pogue,et al. Review of fluorescence guided surgery systems: identification of key performance capabilities beyond indocyanine green imaging , 2016, Journal of biomedical optics.
[32] Alexander L Vahrmeijer,et al. Oncologic Procedures Amenable to Fluorescence-guided Surgery , 2017, Annals of surgery.
[33] E. Rosenthal,et al. Effects of an Unlabeled Loading Dose on Tumor-Specific Uptake of a Fluorescently Labeled Antibody for Optical Surgical Navigation , 2017, Molecular Imaging and Biology.
[34] Jeffrey K. Mito,et al. Intraoperative detection and removal of microscopic residual sarcoma using wide-field imaging , 2012, Cancer.
[35] E. Rosenthal,et al. Fluorescent labeled anti‐EGFR antibody for identification of regional and distant metastasis in a preclinical xenograft model , 2008, Head & neck.
[36] Tayyaba Hasan,et al. Microscopic lymph node tumor burden quantified by macroscopic dual-tracer molecular imaging , 2014, Nature Medicine.
[37] Bin Chen,et al. Fluorescence Imaging in Vivo: Raster Scanned Point-Source Imaging Provides More Accurate Quantification than Broad Beam Geometries , 2004, Technology in cancer research & treatment.
[38] S. Jacques. Optical properties of biological tissues: a review , 2013, Physics in medicine and biology.
[39] A. Stojadinovic,et al. Impact of margin status and local recurrence on soft-tissue sarcoma outcomes. , 2013, The Journal of bone and joint surgery. American volume.
[40] Keith Paulsen,et al. Toxicity and Pharmacokinetic Profile for Single-Dose Injection of ABY-029: a Fluorescent Anti-EGFR Synthetic Affibody Molecule for Human Use , 2017, Molecular Imaging and Biology.
[41] Brian W Pogue,et al. Nodal lymph flow quantified with afferent vessel input function allows differentiation between normal and cancer-bearing nodes. , 2015, Biomedical optics express.
[42] O. Merimsky,et al. Expression and significance of EGFR in malignant peripheral nerve sheath tumor , 2008, Journal of Neuro-Oncology.
[43] Eva M. Sevick-Muraca,et al. Single-Dose Intravenous Toxicity Study of IRDye 800CW in Sprague-Dawley Rats , 2010, Molecular Imaging and Biology.
[44] E. Rosenthal,et al. Use of Panitumumab-IRDye800 to Image Microscopic Head and Neck Cancer in an Orthotopic Surgical Model , 2012, Annals of Surgical Oncology.
[45] Maximilian Burger,et al. Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy. , 2012, The Journal of urology.
[46] F. Zanella,et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. , 2006, The Lancet. Oncology.
[47] H. Park,et al. The effect of microscopic margin status on survival in adult retroperitoneal soft tissue sarcomas. , 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[48] Sophie J Deharvengt,et al. Dynamic dual-tracer MRI-guided fluorescence tomography to quantify receptor density in vivo , 2013, Proceedings of the National Academy of Sciences.
[49] Kevin W Eliceiri,et al. NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.
[50] T. Yamashita,et al. Expression of epidermal growth factor receptor, ERBB2 and KIT in adult soft tissue sarcomas , 2005, Cancer.
[51] Johannes E. Schindelin,et al. Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.